Biosynex SA
PAR:ALBIO

Watchlist Manager

Biosynex SA

PAR:ALBIO

Watchlist

Discount Rate

Price: 3.515 EUR -6.76% Market Closed

Updated: Jun 16, 2024

Have any thoughts about
Biosynex SA?

Write Note

Write Note Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Walt Disney Co NYSE:DIS	Media

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

This note will be permanently deleted.

Delete

Cancel

Ask me anything about

Biosynex SA

What unique competitive advantages
does Biosynex SA hold over its rivals?

What risks and challenges
does Biosynex SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Biosynex SA.

What unique competitive advantages
does Biosynex SA hold over its rivals?

What risks and challenges
does Biosynex SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biosynex SA.

Provide P/S
for Biosynex SA.

Provide P/E
for Biosynex SA.

Provide P/OCF
for Biosynex SA.

Provide P/FCFE
for Biosynex SA.

Provide P/B
for Biosynex SA.

Provide EV/S
for Biosynex SA.

Provide EV/GP
for Biosynex SA.

Provide EV/EBITDA
for Biosynex SA.

Provide EV/EBIT
for Biosynex SA.

Provide EV/OCF
for Biosynex SA.

Provide EV/FCFF
for Biosynex SA.

Provide EV/IC
for Biosynex SA.

Show me price targets
for Biosynex SA made by professional analysts.

What are the Revenue projections
for Biosynex SA?

How accurate were the past Revenue estimates
for Biosynex SA?

What are the Net Income projections
for Biosynex SA?

How accurate were the past Net Income estimates
for Biosynex SA?

What are the EPS projections
for Biosynex SA?

How accurate were the past EPS estimates
for Biosynex SA?

What are the EBIT projections
for Biosynex SA?

How accurate were the past EBIT estimates
for Biosynex SA?

Compare the revenue forecasts
for Biosynex SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biosynex SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biosynex SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biosynex SA compared to its peers.

Compare the P/E ratios
of Biosynex SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Biosynex SA with its peers.

Analyze the financial leverage
of Biosynex SA compared to its main competitors.

Show all profitability ratios
for Biosynex SA.

Provide ROE
for Biosynex SA.

Provide ROA
for Biosynex SA.

Provide ROIC
for Biosynex SA.

Provide ROCE
for Biosynex SA.

Provide Gross Margin
for Biosynex SA.

Provide Operating Margin
for Biosynex SA.

Provide Net Margin
for Biosynex SA.

Provide FCF Margin
for Biosynex SA.

Show all solvency ratios
for Biosynex SA.

Provide D/E Ratio
for Biosynex SA.

Provide D/A Ratio
for Biosynex SA.

Provide Interest Coverage Ratio
for Biosynex SA.

Provide Altman Z-Score Ratio
for Biosynex SA.

Provide Quick Ratio
for Biosynex SA.

Provide Current Ratio
for Biosynex SA.

Provide Cash Ratio
for Biosynex SA.

What is the historical Revenue growth
over the last 5 years for Biosynex SA?

What is the historical Net Income growth
over the last 5 years for Biosynex SA?

What is the current Free Cash Flow
of Biosynex SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biosynex SA.

ALBIO

Cash Flow Statement

Cash from Financing Activities

Biosynex SA
Cash from Financing Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Biosynex SA
Cash from Financing Activities Peer Comparison

Comparables:

EDAP

BIM

ALCAR

ALCOR

AMPLI

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

	Cash from Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Biosynex SA PAR:ALBIO	Cash from Financing Activities €26.8m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Edap Tms SA NASDAQ:EDAP	Cash from Financing Activities €20.3m	CAGR 3-Years 85%	CAGR 5-Years 60%	CAGR 10-Years 26%
Biomerieux SA PAR:BIM	Cash from Financing Activities -€122.3m	CAGR 3-Years 11%	CAGR 5-Years N/A	CAGR 10-Years N/A
Carmat SA PAR:ALCAR	Cash from Financing Activities €15m	CAGR 3-Years -17%	CAGR 5-Years 24%	CAGR 10-Years 0%
Biocorp Production SA PAR:ALCOR	Cash from Financing Activities €1.6m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Amplitude Surgical SA PAR:AMPLI	Cash from Financing Activities -€33.2m	CAGR 3-Years N/A	CAGR 5-Years -45%	CAGR 10-Years N/A

What is Biosynex SA's Cash from Financing Activities?

Cash from Financing Activities
26.8m EUR

Based on the financial report for Dec 31, 2023, Biosynex SA's Cash from Financing Activities amounts to 26.8m EUR.

Biosynex SA
PAR:ALBIO

Biosynex SA
Cash from Financing Activities

Biosynex SA
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

See Also

What is Biosynex SA's Cash from Financing Activities?

Cash from Financing Activities
26.8m EUR

Company

Help

Tools

Stocks

Biosynex SA PAR:ALBIO

Biosynex SA Cash from Financing Activities

Biosynex SA Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis Latest Figures & CAGR of Competitors

See Also

What is Biosynex SA's Cash from Financing Activities? Cash from Financing Activities 26.8m EUR

Company

Help

Tools

Stocks

Biosynex SA
PAR:ALBIO

Biosynex SA
Cash from Financing Activities

Biosynex SA
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

What is Biosynex SA's Cash from Financing Activities?

Cash from Financing Activities
26.8m EUR